KATIE COVINGTON: Open Payments
NPI 1407893217 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 70 payments from 17 companies in 2025. Trend: 2023 $912 · 2024 $1,349 · 2025 $1,421
Food & beverage: $1,421
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 14 | $332 |
| Janssen Biotech, Inc. | 10 | $150 |
| Botanix SB Inc | 8 | $143 |
| Galderma Laboratories, L.P. | 7 | $124 |
| Arcutis Biotherapeutics, Inc. | 5 | $95 |
| ABBVIE INC. | 4 | $89 |
| GENZYME CORPORATION | 2 | $80 |
| Organon LLC | 4 | $75 |
| Lilly USA, LLC | 3 | $57 |
| Incyte Corporation | 2 | $47 |
Products named: ADBRY, TREMFYA, SOFDRA, DUPIXENT, NEMLUVIO, Zoryve, VTAMA, OPZELURA.
Industry payments across GA — which companies pay providers there.
